Ratio Therapeutics Inc. Appoints Marc Becker as Chief Financial Officer and Chief Operating Officer
Position
Chief Financial Officer
Company
Ratio Therapeutics
BostonBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
Ratio Therapeutics Inc. has appointed Marc Becker as the company's Chief Financial Officer and Chief Operating Officer to reinforce Ratio's financial and operational leadership by bringing significant experience in biotech and pharma to guide growth strategies and ensure continued success.
Quick answer
Ratio Therapeutics Inc. Appoints Marc Becker as Chief Financial Officer and Chief Operating Officer (May 6, 2024). Ratio Therapeutics is based in Boston, Massachusetts, United States.
- Who is the new Chief Financial Officer at Ratio Therapeutics?
- Ratio Therapeutics named Marc Becker Chief Financial Officer, announced May 6, 2024.
- What did Ratio Therapeutics announce on May 6, 2024?
- Ratio Therapeutics Inc. has appointed Marc Becker as the company's Chief Financial Officer and Chief Operating Officer to reinforce Ratio's financial and operational leadership by bringing significant experience in biotech and pharma to guide growth strategies and ensure continued success.
- What does Ratio Therapeutics do?
- Ratio Therapeutics Inc. is a clinical-stage pharmaceutical company with the mission to accelerate the development of next-generation precision radiopharmaceuticals for solid tumors and transform oncology treatment...
- Where is Ratio Therapeutics based?
- Ratio Therapeutics is based in Boston, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Pfizer (May 6, 2024), YS Biopharma (May 7, 2024), EyePoint, Inc. (May 9, 2024) and Teva Pharmaceutical Industries Ltd (May 15, 2024) also announced leadership changes within 45 days of Ratio Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Pfizer Inc. names Andrew Baum as Chief Strategy and Innovation Officer, Executive Vice President (May 6, 2024)
- YS Biopharma Appoints Dave Chenn as Interim CEO and Hui Shao as Co-CEO and CBO (May 7, 2024)
- EyePoint Pharmaceuticals, Inc. Appoints Isabelle Lefebvre as Chief Regulatory Officer (May 9, 2024)
- Teva Pharmaceutical Industries Ltd. Appoints Matthew Shields as Executive Vice President of Teva Global Operations (May 15, 2024)
- Oragenics Appoints Dr. William “Frank” Peacock as Chief Clinical Officer for Conducting Phase II Clinical Trial (May 22, 2024)
- Recursion Pharmaceuticals Appoints Najat Khan as Chief Commercial Officer and Head of R&D (April 19, 2024)
Who to call at Ratio Therapeutics, and when
A new leader at Ratio Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Ratio Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ratio Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ratio Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ratio Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Ratio Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.